BIT's 10th Annual World Cancer Congress -2017 (WCC-2017)
Welcome

BIT's 10th Annual World Cancer Congress -2017 (WCC-2017) will be held on 19-21, May 2017 in Barcelona, Spain.

WCC-2017 provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of cancer patients.

WCC-2017 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings into the cause and processes of the disease and recent advances in clinical practice, from prevention to diagnosis, treatment and care.

We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.

Renowned Speakers WCC-2017
Kenneth Olden.jpg Dr. Kenneth Olden, Director, EPA’s National Center for Environmental Assessment, USA Steven T. Rosen.jpg Dr. Steven T. Rosen, Provost & Chief Scientific Officer, City of Hope Comprehensive Cancer Center, USA Karol Sikora.jpg Dr. Karol Sikora, Chief Medical Officer & Dean, Proton Partners International & University of Buckingham Medical School, UK
Bennard van Ravenzwaay.jpg Dr. Bennard van Ravenzwaay, Senior Vice President, BASF SE, Germany Konstantinos Konstantopoulos.jpg Dr. Konstantinos Konstantopoulos, Professor & Chair, The Johns Hopkins University, USA Alvaro Macieira-Coelho.jpg Dr. Alvaro Macieira-Coelho, Director, French National Institute of Health, France
Miquel Pons.jpg Dr. Miquel Pons, Full Professor & Group Leader, Biomolecular NMR Group; Faculty of Chemistry, University of Barcelona, Spain Thierry Virolle.png Dr. Thierry Virolle, Director of Research, INSERM, France Doron Melamed.jpg Dr. Doron Melamed, Professor, Department of Immunology, Faculty of Medicine, Technion, Israel
Dominique Belpomme.png Dr. Dominique Belpomme, Professor, University of Paris; Director, the European Cancer and Environment Research Institute (ECERI), France Juan Sanabria.jpg Dr. Juan Sanabria, Professor, Vice-chair & Scientific Director, Comprehensive Cancer Center, USA Michel Janicot.jpg Dr. Michel Janicot, Founder & CEO, JMi ONConsulting, Belgium
Gerd Birkenmeier.bmp Dr. Gerd Birkenmeier, Professor, University of Leipzig, Germany Fabio Mammano.jpg Dr. Fabio Mammano, Professor & Director, CNR Institute of Cell Biology and Neurobiology, Italy Aikaterini Kontrogianni-Konstantopoulos2.jpg Dr. Aikaterini Kontrogianni-Konstantopoulos, Professor, University of Maryland School of Medicine, USA
Peter L. Elkin.jpg Dr. Peter L. Elkin, Professor & Director, Department of Biomedical Informatics, University at Buffalo, USA Andrei P. Kozlov.png Dr. Andrei P. Kozlov, Professor, Director of Biomedical Center & Chief, Lab of Molecular Virology and Oncology, Peter the Great Polytechnic University, Russia Steven Eror.jpg Mr. Steven Eror, President & CEO, ProLungdx, USA
Paul S. Rennie.jpg Dr. Paul S. Rennie, Professor & Director, Laboratory Research, The Vancouver Prostate Centre & University of British Columbia, Canada Karim Malik.jpg Dr. Karim Malik, Reader & Associate Professor, University of Bristol, UK Giulio Tarro.jpg Dr. Giulio Tarro, President, Foundation de Beaumont Bonelli for Cancer Research, Italy
Nira Ben-Jonathan.bmp Dr. Nira Ben-Jonathan, Professor, University of Cincinnati, USA Jan Groen.jpg  Dr. Jan Groen, CEO, MDxHealth, Belgium Steven Warner.jpg Dr. Steven Warner, VP, Discovery and Development, Tolero Pharmaceuticals Inc., USA
Mohamed Aziz.jpg Dr. Mohamed Aziz, Senior Surgical Pathologist, USA; Professor of Pathology, American University of the Caribbean Medical School, St. Maarten, Dutch Antilles Masahiro Tsubaki.jpg Dr. Masahiro Tsubaki, Vice President, Yuai Memorial Hospital, Japan Brigitte Guérin.jpg Dr. Brigitte Guerin, Full Professor, Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Canada
Colleen Huber.jpg Dr. Colleen Huber, President & Medical Director, Naturopathic Cancer Society & Nature Works Best Cancer Clinic, USA Dimcho Bachvarov.jpg Dr. Dimcho Bachvarov, Professor, Laval University, Canada Nathalie Rivard2.jpg Dr. Nathalie Rivard, Full Professor & Director, Universite de Sherbrooke, Canada
Dr. Eva Estebanez-Perpina, Associate Professor & Serra Hunter Fellow, Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona (IBUB), Spain        
Previous Event Report
Exhibition and Poster

As part of the 2017 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.

       

Exhibition Date:
Set-up date: May 18, 2017
Show dates: May 19-21, 2017 09:00-18:00
Place: Barcelona, Spain

Hosting Organization
whtslogo.JPG
World High Technology Society
Operating Organization

BIT Group Global Ltd.

International Honorary Chairman

Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.